Anixa Biosciences, Inc.
(NASDAQ : ITUS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Electronic Technology » Computer Peripherals
symbolcompany%chnglast%shortavg$volume
WDCWestern Digital Corporation
-0.28%46.602.2%$332.70m
NTAPNetApp, Inc.
4.38%71.902.9%$248.01m
STXSeagate Technology PLC
-1.28%43.309.1%$219.17m
ZBRAZebra Technologies Corporation Class A
1.00%180.704.1%$94.03m
PSTGPure Storage, Inc. Class A
-1.85%19.136.8%$62.62m
SYNASynaptics Incorporated
0.22%37.2518.5%$26.35m
EFIIElectronics For Imaging, Inc.
0.00%28.0613.6%$14.08m
LOGILogitech International S.A.
-0.97%34.614.9%$11.11m
IMMRImmersion Corporation
-1.44%9.565.1%$2.83m
AVIDAvid Technology, Inc.
-2.10%6.5212.0%$1.17m
QTMQuantum Corporation
-11.45%2.630.6%$0.66m
ITIIteris, Inc.
0.90%4.500.0%$0.38m
ALOTAstro-Med, Inc.
-1.40%18.990.6%$0.25m
ICADiCAD, Inc.
-0.35%2.890.5%$0.21m
BCLIBrainstorm Cell Therapeutics Inc.
0.00%3.155.2%$0.16m

Company Profile

Anixa Biosciences, Inc. engages in the development, acquisition and licensing emerging technology in the field of biotechnology. It focuses on platform called Cchek, a series of inexpensive non-invasive blood tests for the early detection of cancer, which is based on the body's immunological response to the presence of a malignancy. The company was founded on November 5, 1982 and is headquartered San Jose, CA.